Trial NCT04162873

View at ClinicalTrials.gov 
Org. Study IDs: HCI124211
Secondary IDs: HCI124211 NCI-2019-07104 P30CA042014

Last trial update was posted on 2024-02-13

MeSH Interventions

Celecoxib

MeSH Conditions

Carcinoma Head and Neck Neoplasms Laryngeal Neoplasms Oropharyngeal Neoplasms Paranasal Sinus Neoplasms Recurrence

Other Conditions

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Nasal Cavity and Paranasal Sinus Carcinoma Oral Cavity Carcinoma Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Recurrent Hypopharyngeal Carcinoma Recurrent Laryngeal Carcinoma Recurrent Nasal Cavity and Paranasal Sinus Carcinoma Recurrent Oral Cavity Carcinoma Recurrent Oropharyngeal Carcinoma Stage III Hypopharyngeal Carcinoma AJCC v8 Stage III Laryngeal Cancer AJCC v8 Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IV Hypopharyngeal Carcinoma AJCC v8 Stage IV Laryngeal Cancer AJCC v8 Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVA Hypopharyngeal Carcinoma AJCC v8 Stage IVA Laryngeal Cancer AJCC v8 Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVB Hypopharyngeal Carcinoma AJCC v8 Stage IVB Laryngeal Cancer AJCC v8 Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVC Hypopharyngeal Carcinoma AJCC v8 Stage IVC Laryngeal Cancer AJCC v8 Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Stopping Reasons

Pending confirmation of additional funding

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID